Biotech Calendar: Upcoming FDA Dates
A quick and dirty guide to the expected regulatory news from the FDA through June 2010.
04:25PM 12/14/09
Biotech Stock Mailbag: Cell Therapeutics
Biotech columnist Adam Feuerstein answers reader email about Cell Therapeutics and other stocks.
07:00AM 12/11/09
Cell Therapeutics on Dilution Watch: BioBuzz
CEO spotted in New York with bankers in tow, looking at his wallet.
02:16PM 12/08/09
Judges: Seattle Biotech Can Pursue $23M Claim
Federal appeals court: Seattle biotech can pursue $23 million claim against former consultant
08:08PM 11/18/09
Poniard's CEO Pulls a Belichick: BioBuzz
Risky late-game call puts Poniard in a deep financial hole.
11:59AM 11/16/09
A Closer Look at Cardium's Wound-Healing Drug: BioBuzz
Is it the drug or the gel that worked best in a phase II study?
10:51AM 11/16/09
Cell Therapeutics Lavishes Free Stock on Execs: BioBuzz
'Retention' bonus awarded to CEO Jim Bianco, his management team and directors.
09:23AM 11/16/09
Oculus, Bianco and Cel-Sci Oh My!: BioBuzz
Some Friday Fall tidbits from the biotech stock world.
10:53AM 11/06/09
Apple, Google Can Right the Ship (RealMoney.com $)
These are the stocks that are going to make people feel that they have a chance to get back to even.
11:28AM 10/12/09
Midday Movers: Pump Up the Volume
Several small-cap stocks were moving on above-average volume during Thursday's session.
02:05PM 10/08/09
By Alix Steel | By Adam Feuerstein
From the Best of TSC TV: BOSTON (TheStreet) - Adam Feuerstein, senior biotech reporter, talks swine flu, small cap stock, healthcare reform, speculative stocks and Dendreon. Watch this video to see Adam's top biotech stock picks. original air date: 09/29/2009.
05:00PM 10/04/09
By Alix Steel | By Adam Feuerstein
BOSTON (TheStreet) -- Adam Feuerstein, senior biotech reporter, breaks down the biotech stocks you want to know about and how to trade them.
12:00PM 10/02/09
Cell Therapeutics' Opaxio Data Not Terrible: BioBuzz
More work needs to be done before penciling in approval.
02:25PM 10/01/09
Cell Therapeutics Seeks EU Aid For Cancer Drug
Cell Therapeutics says it asked EU regulators to grant orphan drug status to pixantrone
05:14PM 09/29/09
By Alix Steel | By Adam Feuerstein
BOSTON (TheStreet) - Adam Feuerstein, senior biotech reporter, talks swine flu, small cap stock, healthcare reform, speculative stocks and Dendreon. Watch this video to see Adam's top biotech stock picks.
02:12PM 09/29/09



Connect with TheStreet